Austar Lifesciences Limited (6118.HK)
HKD 0.81
(0.0%)
HKD 0.81
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -62.64 Million | -37.92 Million | -103.45 Million | 52.22 Million | 37.79 Million | -77.59 Million |
| Net Income | -34.41 Million | 87.46 Million | 277.3 Million | 33.1 Million | 8.09 Million | 107 Thousand |
| Depreciation & Amortization | 45.59 Million | 36.53 Million | 29.61 Million | 29.83 Million | 24.59 Million | 7.57 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -125.07 Million | -269.12 Million | -481.79 Million | -40.69 Million | -60.16 Million | -144.25 Million |
| Other non-cash items | 7.95 Million | 107.19 Million | 71.42 Million | 29.97 Million | 65.27 Million | 58.97 Million |
| Investing Cash Flow | -54.46 Million | -153.14 Million | 65.02 Million | -59.8 Million | -22.08 Million | -39.49 Million |
| Investments in PPE | -70.94 Million | -117.32 Million | -100.57 Million | -26.54 Million | -13.72 Million | -5.18 Million |
| Acquisitions | - | -28.64 Million | 185.39 Million | - | -7.45 Million | -31 Thousand |
| Investment purchases | -10 Million | -14.5 Million | -21.29 Million | - | - | - |
| Sales/Maturities of investments | 14.5 Million | 21.29 Million | 162 Thousand | 47 Thousand | - | - |
| Other Investing Activities | -5.53 Million | -13.96 Million | 1.33 Million | -33.31 Million | -911 Thousand | -34.27 Million |
| Financing Cash Flow | 147.11 Million | 125.3 Million | 59.34 Million | -5.51 Million | -20.69 Million | 4.44 Million |
| Debt repayment | -180.8 Million | -116.38 Million | -45.35 Million | -47.56 Million | -10.05 Million | -20 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9.62 Million | 241.69 Million | 104.69 Million | 42.05 Million | -10.64 Million | 24.44 Million |
| Accounts receivables | -2.33 Million | -293.72 Million | -259.1 Million | 6.58 Million | -16.27 Million | -89.64 Million |
| Accounts payables | - | -68.46 Million | 44.39 Million | 39.14 Million | -8.03 Million | - |
| Inventory | 85.54 Million | 24.59 Million | -222.69 Million | -47.27 Million | -43.89 Million | -54.6 Million |
| Other working capital | 67.47 Million | 68.46 Million | -44.39 Million | -39.14 Million | 8.03 Million | -88.94 Million |
| Cash at beginning of period | 133.62 Million | 198.44 Million | 177.94 Million | 191.08 Million | 196.45 Million | 309.32 Million |
| Cash at end of period | 163.76 Million | 133.62 Million | 198.44 Million | 177.94 Million | 191.08 Million | 196.45 Million |
| Capital Expenditure | -70.94 Million | -117.32 Million | -100.57 Million | -26.54 Million | -13.72 Million | -5.18 Million |
| Effect of forex changes on cash | 142 Thousand | 945 Thousand | -422 Thousand | -40 Thousand | -387 Thousand | -208 Thousand |
| Net cash flow / Change in cash | 30.14 Million | -64.82 Million | 20.49 Million | -13.13 Million | -5.37 Million | -112.86 Million |
| Free Cash Flow | -133.59 Million | -155.25 Million | -204.02 Million | 25.68 Million | 24.06 Million | -82.78 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.87 Million | - | -34.41 Million | -39.94 Million | 87.46 Million | 41.61 Million |
| Depreciation & Amortization | 25.21 Million | - | 45.59 Million | 17.99 Million | 36.53 Million | 22.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -125.07 Million | - | -269.12 Million | -200.66 Million |
| Other non-cash items | -11.55 Million | - | 7.95 Million | -42.88 Million | 107.19 Million | 141.45 Million |
| Investing Cash Flow | 12.35 Million | - | -54.46 Million | -25.36 Million | -153.14 Million | -73.7 Million |
| Investments in PPE | -5.57 Million | - | -70.94 Million | -34.53 Million | -117.32 Million | -33.62 Million |
| Acquisitions | - | - | - | - | -28.64 Million | - |
| Investment purchases | - | - | -10 Million | - | -14.5 Million | - |
| Sales/Maturities of investments | - | - | 14.5 Million | - | 21.29 Million | - |
| Other Investing Activities | 17.92 Million | - | -5.53 Million | 9.17 Million | -13.96 Million | -40.07 Million |
| Financing Cash Flow | -56 Million | - | 147.11 Million | 82.37 Million | 125.3 Million | 22.67 Million |
| Debt repayment | -46.98 Million | - | -180.8 Million | -89.05 Million | -116.38 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9.02 Million | - | -9.62 Million | -6.68 Million | 241.69 Million | 22.67 Million |
| Accounts receivables | - | - | -2.33 Million | - | -293.72 Million | -293.72 Million |
| Accounts payables | - | - | - | - | -68.46 Million | - |
| Inventory | - | - | 85.54 Million | - | 24.59 Million | 24.59 Million |
| Other working capital | - | - | 67.47 Million | - | 68.46 Million | 68.46 Million |
| Cash at beginning of period | 163.76 Million | 125.89 Million | 133.62 Million | 133.62 Million | 198.44 Million | 178.8 Million |
| Cash at end of period | 139.98 Million | 125.89 Million | 163.76 Million | 125.89 Million | 133.62 Million | 133.62 Million |
| Capital Expenditure | -5.57 Million | - | -70.94 Million | -34.53 Million | -117.32 Million | -33.62 Million |
| Effect of forex changes on cash | 336 Thousand | - | 142 Thousand | 93 Thousand | 945 Thousand | 1.23 Million |
| Net cash flow / Change in cash | -23.78 Million | - | 30.14 Million | -7.73 Million | -64.82 Million | -45.17 Million |
| Free Cash Flow | 13.96 Million | - | -133.59 Million | -99.36 Million | -155.25 Million | -29 Million |
6694
MOBX
FCH
SPTY
TGT
2169